CD96 as a Potential Diagnostic Biomarker and  New  Target for Skin Cutaneous Melanoma

Figure 1

CD96 was upregulated in skin cutaneous melanoma. (a) The expression level of CD96 was increased in multiple types of tumors compared with normal samples. (b) The expression level of CD96 was increased in skin cutaneous melanoma compared with normal skin samples. (c) Significant relationship was found in skin cutaneous melanoma tumor stage with CD96 expression level by GEPIA (  < 0.05,  < 0.01, and  < 0.001).

(a)

(b)

(c)